This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08545/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08545/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08545/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08545/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08545
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08545 n11:DB08545
dcterms:title
(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE
adms:identifier
n6:DB08545 n7:99445016 n12:SH4 n13:46937159
n3:IUPAC-Name
n4:271B6283-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6289-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6288-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6285-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6286-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6287-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6281-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B627F-363D-11E5-9242-09173F13E4C5 n4:271B6282-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6280-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B628F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6290-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B628A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B628B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B628D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B628C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B628E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6295-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6297-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6298-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6294-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6293-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6296-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6284-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6291-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6292-363D-11E5-9242-09173F13E4C5